-
Name:Upamostat
Catalog No.:B0004
Structure:
Chemical Properties Cas No.:590368-25-5 Purity Limit: Synonyms: Molecular Weight:629.32 Formula:C32H47N5O6S Storage: Solubility:
Shipping Condition
Quality Control & MSDS
Description Upamostat, also known as Mesupron, WX-671, is an orally bioavailable, 3-amidinophenylalanine-derived, second generation serine protease inhibitor prodrug targeting the human urokinase plasminogen activator (uPA) system with potential antineoplastic and antimetastatic activities. After oral administration, serine protease inhibitor WX-671 is converted to the active Nα-(2,4,6-triisopropylphenylsulfonyl)-3-amidino-(L)-phenyla lanine-4-ethoxycarbonylpiperazide (WX-UK1), which inhibits several serine proteases, particularly uPA; inhibition of uPA may result in the inhibition of tumor growth and metastasis. uPA is a serine protease involved in degradation of the extracellular matrix and tumor cell migration and proliferation
References Related products
- Boceprevir
- Atazanavir
- Tenofovir alafenamide
- Telaprevir
- Ixazomib
- Odanacatib
- L685458
- Emricasan
- Belnacasan
- Cobicistat
Tel: +86-411-39042497
sales@alphabiopham.com
Contact us now!
We'll offer you the best prices